AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2015
Aug 4, 2015
31982_dirs_2015-08-04_8379558c-d235-4dbc-bc1e-91e34538b7cc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2015-07-31
Reporting Person: Glenn Gregory M (SVP, Research and Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-31 | Common Stock | P | 892 | $2.28 | Acquired | 1158 | Direct |
Footnotes
F1: Includes 892 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on July 31, 2015.